Published in Virus Weekly, February 9th, 1998
"I think we can go out on a limb and say there is a pretty good chance that we may be able to eradicate this major worldwide cause of death within the next 30 to 50 years," Nathaniel A. Brown of Glaxo Wellcome, Inc (Research Triangle Park, NC) said in a presentation to the IBC Fourth Annual International Industry Congress on Hepatitis, held January 22-23, 1998 in Washington, D.C.
Brown presented a report on the use of the Glaxo Wellcome agent lamivudine, now in worldwide phase III...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Virus Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.